MGLIX | TGREX | MGLIX / TGREX | |
Total Expense Ratio | 0.94 | 0.90 | 104% |
Annual Report Gross Expense Ratio | 0.95 | 1.42 | 67% |
Fund Existence | 16 years | 10 years | - |
Gain YTD | -0.249 | 1.725 | -14% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 2000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 2.23B | 40.3M | 5,529% |
Annual Yield % from dividends | 2.60 | 1.98 | 131% |
Returns for 1 year | 3.12 | 3.47 | 90% |
Returns for 3 years | -9.73 | 5.37 | -181% |
Returns for 5 years | 20.89 | 35.81 | 58% |
Returns for 10 years | 24.83 | 44.90 | 55% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
SEKIX | 19.86 | 0.08 | +0.40% |
DWS Emerging Markets Equity Inst | |||
IVGTX | 16.46 | -0.06 | -0.36% |
VY® Morgan Stanley Global Franchise S | |||
FCGAX | 135.02 | -0.63 | -0.46% |
Franklin Growth Adv | |||
NWCCX | 39.37 | -0.30 | -0.76% |
Nuveen Winslow Large-Cap Growth ESG C | |||
NGRDX | 29.24 | -0.32 | -1.08% |
Neuberger Berman Large Cap Growth R6 |